Log in

Relevant bibliographies by topics / Metabolic cardiovascular syndrome / Journal articles

To see the other types of publications on this topic, follow the link: Metabolic cardiovascular syndrome.

Journal articles on the topic 'Metabolic cardiovascular syndrome'

Author: Grafiati

Published: 4 June 2021

Last updated: 8 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Metabolic cardiovascular syndrome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Karimova, Maksuda Ahmedjanovna, and Dilnoza Kakhramanovna Kurbanbaeva. "Problems Of Metabolic Syndrome." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (2021): 52–55. http://dx.doi.org/10.37547/tajmspr/volume03issue06-08.

Full text

Abstract:

At the beginning of the third millennium, for mankind, which overcame the epidemic of life-threatening infections during its centuries-old history, the problem of cardiovascular diseases (CVD) came to the fore in relevance among all causes of morbidity and mortality. A significant role in this was played by lifestyle modification associated with limiting physical activity, increasing the calorie content of food, and a steady increase in emotional stress. All of this potentiates the main risk factors for CVD, which are a “negative asset of progress,” namely increased blood pressure (BP), dyslip

APA, Harvard, Vancouver, ISO, and other styles

2

Hjermann, Ingvar. "The Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S5—S10. http://dx.doi.org/10.1097/00005344-199220008-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Jain, Vikas, S. K. Dwivedi, and R. K. Sharma. "Association of Metabolic Syndrome Parameters with Exercise Capacity and Cardiovascular Parameters." International Physiology 6, no. 2 (2018): 148–55. http://dx.doi.org/10.21088/ip.2347.1506.6218.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Citrome, Leslie. "Metabolic Syndrome and Cardiovascular Disease." Journal of Psychopharmacology 19, no. 6_suppl (2005): 84–93. http://dx.doi.org/10.1177/0269881105058375.

Full text

Abstract:

Metabolic syndrome is a constellation of clinical findings that identify individuals at higher than normal risk of developing diabetes mellitus or cardiovascular disease. There are two principal definitions, one emerging from the American National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, and the other from the World Health Organization. Both definitions share the common elements of abdominal obesity, hypertriglyceridaemia, low HDL-cholesterol, hypertension and abnormal glucose regulation. The syndrome is relatively

APA, Harvard, Vancouver, ISO, and other styles

5

Cha, Bong Soo, and Hae Jin Kim. "Metabolic Syndrome and Cardiovascular Disease." Korean Circulation Journal 33, no. 8 (2003): 645. http://dx.doi.org/10.4070/kcj.2003.33.8.645.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rocha, Evangelista. "Metabolic syndrome and cardiovascular risk." Revista Portuguesa de Cardiologia (English Edition) 38, no. 5 (2019): 333–35. http://dx.doi.org/10.1016/j.repce.2019.06.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Tune, Johnathan D., Adam G. Goodwill, Daniel J. Sassoon, and Kieren J. Mather. "Cardiovascular consequences of metabolic syndrome." Translational Research 183 (May 2017): 57–70. http://dx.doi.org/10.1016/j.trsl.2017.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Krentz, Andrew J., Nathan D. Wong, Andrew J. Krent, and Nathan D. Wong. "METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE." Shock 27, no. 5 (2007): 591. http://dx.doi.org/10.1097/01.shk.0000258381.48362.80.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rocha, Evangelista. "Metabolic syndrome and cardiovascular risk." Revista Portuguesa de Cardiologia 38, no. 5 (2019): 333–35. http://dx.doi.org/10.1016/j.repc.2019.06.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Arnesen, Harald. "Introduction: The Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S1—S4. http://dx.doi.org/10.1097/00005344-199200208-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Alshehri, AbdullahM. "Metabolic syndrome and cardiovascular risk." Journal of Family and Community Medicine 17, no. 2 (2010): 73. http://dx.doi.org/10.4103/1319-1683.71987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Sorrentino, Matthew J. "Metabolic Syndrome and Cardiovascular Disease." Medicine & Science in Sports & Exercise 39, no. 6 (2007): 1027. http://dx.doi.org/10.1249/mss.0b013e318074e839.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Qiao, Qing, Weiguo Gao, Lei Zhang, Regzedmaa Nyamdorj, and Jaakko Tuomilehto. "Metabolic syndrome and cardiovascular disease." Annals of Clinical Biochemistry 44, no. 3 (2007): 232–63. http://dx.doi.org/10.1258/000456307780480963.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Siddiqui, M. Shadab, and Richard K. Sterling. "Posttransplant Metabolic Syndrome." International Journal of Hepatology 2012 (2012): 1–6. http://dx.doi.org/10.1155/2012/891516.

Full text

Abstract:

Metabolic syndrome (MS) is a cluster of metabolic derangements associated with insulin resistance and an increased risk of cardiovascular mortality. MS has become a major health concern worldwide and is considered to be the etiology of the current epidemic of diabetes and cardiovascular disease. In addition to cardiovascular disease, the presence of MS is also closely associated with other comorbidities including nonalcoholic fatty liver disease (NAFLD). The prevalence of MS in patients with cirrhosis and end-stage liver disease is not well established and difficult to ascertain. Following liv

APA, Harvard, Vancouver, ISO, and other styles

15

Adnan, Muhammad, Tayyaba Rahat, Naheed Hashmat, and Zahra Ali. "METABOLIC SYNDROME;." Professional Medical Journal 24, no. 04 (2017): 539–44. http://dx.doi.org/10.29309/tpmj/2017.24.04.1442.

Full text

Abstract:

Background: Metabolic syndrome and diabetes mellitus are the modifiable riskfactors of cardiovascular diseases that double the chance of illness when occur together. Littlework has been reported on the superlative criteria to diagnose metabolic syndrome amongdiabetics from the country. Therefore, the study was aimed to find the agreement betweenmetabolic syndrome diagnostic criteria among type 2 diabetics. Methods: The retrospectivedata of 373 known type 2 diabetics who had reported history of taking antidiabetic medicineswas analyzed. The new International Diabetes Federation definition, the

APA, Harvard, Vancouver, ISO, and other styles

16

BEJAN, Gabriel Cristian, Liviu Nicolae GHILENCEA, Mihaela Adela IANCU, Mihaela Daniela BALTĂ, and Dumitru MATEI. "The impact of modern cardiovascular risk factors associated with metabolic syndrome on long-term outcome." Romanian Journal of Medical Practice 10, no. 4 (2015): 380–87. http://dx.doi.org/10.37897/rjmp.2015.4.12.

Full text

Abstract:

Metabolic syndrome is also called insulin resistance syndrome or catecholamine excess syndrome and is a cluster of cardiometabolic factors that result in increased incidence of cardiovascular disease and diabetes type 2. Due to sedentary lifestyle and hypercaloric diet with an increased content of saturated fat and carbohydrates that characterizes modern life style of the population, especially in urban areas, the prevalence of metabolic syndrome is increasing, thus becoming a very topical issue for the medical world. During the years 2013-2014 we conducted an observational study on a sample o

APA, Harvard, Vancouver, ISO, and other styles

17

McNamara, Anthony. "Metabolic syndrome." InnovAiT: Education and inspiration for general practice 12, no. 10 (2019): 582–88. http://dx.doi.org/10.1177/1755738019864615.

Full text

Abstract:

Metabolic syndrome is the name given to a combination of cardiovascular risk factors. These include hyperinsulinaemia, impaired glucose tolerance, hypertension, central obesity and dyslipidaemia. People with metabolic syndrome have a high risk of developing type 2 diabetes, non-alcoholic fatty liver disease, and vascular conditions including coronary artery disease, peripheral vascular disease, and stroke. Central obesity can predispose to sleep apnoea and restrictive lung disease. For many years, it has been taught that the underlying mechanism of metabolic syndrome is insulin resistance seco

APA, Harvard, Vancouver, ISO, and other styles

18

Hu, Gang, Qing Qiao, and Jaakko Tuomilehto. "The Metabolic Syndrome and Cardiovascular Risk." Current Diabetes Reviews 1, no. 2 (2005): 137–43. http://dx.doi.org/10.2174/1573399054022820.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Huang, Paul L. "eNOS, metabolic syndrome and cardiovascular disease." Trends in Endocrinology & Metabolism 20, no. 6 (2009): 295–302. http://dx.doi.org/10.1016/j.tem.2009.03.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Shimamoto, Kazuaki. "2. Metabolic Syndrome and Cardiovascular Disease." Nihon Naika Gakkai Zasshi 97, no. 3 (2008): 591–97. http://dx.doi.org/10.2169/naika.97.591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Rutter, Martin K., James B. Meigs, and Peter W. F. Wilson. "Cardiovascular Risk and the Metabolic Syndrome." Metabolic Syndrome and Related Disorders 4, no. 4 (2006): 252–60. http://dx.doi.org/10.1089/met.2006.4.252.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Tremblay, Angelo. "Physical activity and metabolic cardiovascular syndrome." British Journal of Nutrition 80, no. 3 (1998): 215–16. http://dx.doi.org/10.1017/s000711459800124x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Altinbas, Kursat, Filiz Alkan, Serhat Tuni, and Sema Yesilyurt. "Metabolic syndrome related cardiovascular disease risk." International Clinical Psychopharmacology 26 (September 2011): e40-e41. http://dx.doi.org/10.1097/01.yic.0000405699.60866.b7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Os, Ingrid, and Gudmund Nordby. "Hypertension and the Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S15—S21. http://dx.doi.org/10.1097/00005344-199220008-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Hjelmesæth, Jøran, Anders Hartmann, Karsten Midtvedt, et al. "Metabolic cardiovascular syndrome after renal transplantation." Nephrology Dialysis Transplantation 16, no. 5 (2001): 1047–52. http://dx.doi.org/10.1093/ndt/16.5.1047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Aggoun, Yacine. "Obesity, Metabolic Syndrome, and Cardiovascular Disease." Pediatric Research 61, no. 6 (2007): 653–59. http://dx.doi.org/10.1203/pdr.0b013e31805d8a8c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Bonora, Enzo. "The metabolic syndrome and cardiovascular disease." Annals of Medicine 38, no. 1 (2006): 64–80. http://dx.doi.org/10.1080/07853890500401234.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Grundy, Scott M. "Obesity, Metabolic Syndrome, and Cardiovascular Disease." Journal of Clinical Endocrinology & Metabolism 89, no. 6 (2004): 2595–600. http://dx.doi.org/10.1210/jc.2004-0372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Nestel, Paul. "Metabolic syndrome: the new cardiovascular target." Current Opinion in Lipidology 15, no. 1 (2004): 1–3. http://dx.doi.org/10.1097/00041433-200402000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Mottillo, Salvatore, Kristian B. Filion, Jacques Genest, et al. "The Metabolic Syndrome and Cardiovascular Risk." Journal of the American College of Cardiology 56, no. 14 (2010): 1113–32. http://dx.doi.org/10.1016/j.jacc.2010.05.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Tzimas, Petros, and Haralampos Milionis. "Metabolic Syndrome." Angiology 68, no. 4 (2016): 304–5. http://dx.doi.org/10.1177/0003319716669461.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Golomb, Beatrice A. "Metabolic Syndrome." Journal of the American College of Cardiology 53, no. 24 (2009): 2280–82. http://dx.doi.org/10.1016/j.jacc.2009.03.029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Denke, Margo A. "Metabolic syndrome." Current Atherosclerosis Reports 4, no. 6 (2002): 444–47. http://dx.doi.org/10.1007/s11883-002-0048-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Caglayan, Evren, Florian Blaschke, Yasunori Takata, and Willa A. Hsueh. "Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways." Current Opinion in Pharmacology 5, no. 2 (2005): 135–42. http://dx.doi.org/10.1016/j.coph.2005.01.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Cheng, Tsung O. "The metabolic syndrome, formerly called metabolic “Syndrome X”." American Journal of Cardiology 94, no. 1 (2004): 148–49. http://dx.doi.org/10.1016/j.amjcard.2004.03.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Pivonello, Rosario, Antongiulio Faggiano, Gaetano Lombardi, and Annamaria Colao. "The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome." Endocrinology and Metabolism Clinics of North America 34, no. 2 (2005): 327–39. http://dx.doi.org/10.1016/j.ecl.2005.01.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Dandona, Paresh, Ahmad Aljada, Ajay Chaudhuri, Priya Mohanty, and Rajesh Garg. "Metabolic Syndrome." Circulation 111, no. 11 (2005): 1448–54. http://dx.doi.org/10.1161/01.cir.0000158483.13093.9d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

BEJAN, Gabriel Cristian, Dumitru MATEI, and Adela IANCU. "Prevalence of metabolic syndrome within hypertensive population and the risk of developing atherosclerotic cardiovascular diseases." Romanian Journal of Medical Practice 10, no. 2 (2015): 187–94. http://dx.doi.org/10.37897/rjmp.2015.2.17.

Full text

Abstract:

Metabolic syndrome, also called insulin resistance syndrome or excess of catecholamines, is represented by several cardiometabolic factors that result in increased incidence of cardiovascular disease and type 2 diabetes. Due to sedentary lifestyle and hypercaloric food, with a high percent of saturated fats and carbohydrates, that characterize modern lifestyle of the population, especially in urban areas, the prevalence of metabolic syndrome recorded an ascending slope that makes it a very topical issue for the medical world. During the years 2013-2014 we conducted an observational study on a

APA, Harvard, Vancouver, ISO, and other styles

39

de la Sierra, Alejandro. "The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk." High Blood Pressure & Cardiovascular Prevention 15, no. 2 (2008): 53–57. http://dx.doi.org/10.2165/00151642-200815020-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Sarzani, Riccardo. "The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk." High Blood Pressure & Cardiovascular Prevention 15, no. 2 (2008): 59–62. http://dx.doi.org/10.2165/00151642-200815020-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Okamoto, Yoshihisa. "Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome." Cardiology Research and Practice 2011 (2011): 1–7. http://dx.doi.org/10.4061/2011/313179.

Full text

Abstract:

Adipose tissue plays a central role in the pathogenesis of metabolic syndrome. Adiponectin (APN) is a bioactive adipocytokine secreted from adipocytes. Low plasma APN levels (hypoadiponectinemia) are observed among obese individuals and in those with related disorders such as diabetes, hypertension, and dyslipidemia. APN ameliorates such disorders. Hypoadiponectinemia is also associated with major cardiovascular diseases including atherosclerosis and cardiac hypertrophy. Accumulating evidence indicates that APN directly interacts with cardiovascular tissue and prevents cardiovascular pathology

APA, Harvard, Vancouver, ISO, and other styles

42

Hjermann, Ingvar. "The Metabolic Cardiovascular Syndrome: Syndrome X, Reavenʼs Syndrome, Insulin Resistance Syndrome, Atherothrombogenic Syndrome". Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S5—S10. http://dx.doi.org/10.1097/00005344-199200208-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Montecucco, Fabrizio, Luca Liberale, and Federico Carbone. "Novel cardiovascular risk biomarkers in metabolic syndrome." Biomarkers in Medicine 13, no. 16 (2019): 1331–34. http://dx.doi.org/10.2217/bmm-2019-0366.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Zhou, Ji-Yin, Lawrence Chan, and Shi-Wen Zhou. "Omentin: Linking Metabolic Syndrome and Cardiovascular Disease." Current Vascular Pharmacology 12, no. 1 (2014): 136–43. http://dx.doi.org/10.2174/1570161112999140217095038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Nesto, Richard W. "Managing cardiovascular risk inpatients with metabolic syndrome." Clinical Cornerstone 7, no. 2-3 (2005): 46–51. http://dx.doi.org/10.1016/s1098-3597(05)80067-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Grundy, Scott M. "Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor." Journal of Clinical Endocrinology & Metabolism 92, no. 2 (2007): 399–404. http://dx.doi.org/10.1210/jc.2006-0513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Kawada, Tomoyuki. "Smoking, hyperhomocysteinemia, metabolic syndrome, and cardiovascular risk." Nutrition 81 (January 2021): 111031. http://dx.doi.org/10.1016/j.nut.2020.111031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Blomhoff, Jan P. "Lipoproteins, Lipases, and the Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S22—S25. http://dx.doi.org/10.1097/00005344-199200208-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Westheim, Arne, and Ingrid Os. "Physical Activity and the Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S49—S53. http://dx.doi.org/10.1097/00005344-199200208-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Blomhoff, Jan P. "Lipoproteins, Lipases, and the Metabolic Cardiovascular Syndrome." Journal of Cardiovascular Pharmacology 20, Supplement 8 (1992): S22—S25. http://dx.doi.org/10.1097/00005344-199220008-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!